Imagine a world where daily insulin injections could be a thing of the past.Well, this scenario could be closer than we think.
The Biotts company, based in Wrocław, Poland, has successfully completed a concept proof project for the transdermal insulin administration.What makes this approach special is that insulin is managed by a patch applied to the skin, eliminating the need for injections.
This study, carried out in collaboration with Bioton, showed very promising results.The insulin administered through these patches not only managed to be effectively absorbed by the body, but also maintained constant levels of insulin for at least five days.This is significantly longer than injected insulin, which usually lasts less than a day.
One of the most notable benefits is the stability in the insulin concentration profile offered by this method.This is crucial to avoid sudden fluctuations in blood sugar levels that we fear so many of us.In addition, preliminary results suggest that a single patch could replace up to 20 insulin injections, which is incredibly good news for those who seek comfort without compromising effectiveness.
Think about the impact that this could have on children with type 1 diabetes and those who live in regions where access to medical care is limited.Not only will it improve the quality of life, but it will also help reduce medical waste.
It is important to mention that these developments are still in the initial stages and the products are expected to be available in the market by 2027. However, the potential to significantly improve our way of handling diabetes is immense.
For those interested in reading more about the study, they can do it at Link
The perspective of a life without daily injections could be right on the horizon.
Greetings,